F-star Therapeutics Inc

NASDAQ:FSTX   3:59:51 PM EDT
6.90
-0.12 (-1.71%)
Earnings Announcements

F-star Therapeutics Reports Q2 Loss Per Share Of $0.92

Published: 08/12/2021 12:24 GMT
F-star Therapeutics Inc (FSTX) - Q2 Loss per Share $0.92.
Cash and Cash Equivalents As of June 30, 2021, Were $81.6 Million, Compared to $18.5 Million at December 31, 2020.
Revenue is expected to be $3.7 Million
Adjusted EPS is expected to be -$0.58

Next Quarter Revenue Guidance is expected to be $1.88 Million
Next Quarter EPS Guidance is expected to be -$0.70

More details on our Analysts Page.